• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pharmacovigilance-based drug repurposing: The search for inverse signals via OpenVigil identifies putative drugs against viral respiratory infections.

作者信息

Böhm Ruwen, Bulin Claudia, Waetzig Vicki, Cascorbi Ingolf, Klein Hans-Joachim, Herdegen Thomas

机构信息

Institute of Experimental and Clinical Pharmacology, University Hospital Schleswig-Holstein Campus Kiel, Germany.

Department of Computer Science, Kiel University, Germany.

出版信息

Br J Clin Pharmacol. 2021 Nov;87(11):4421-4431. doi: 10.1111/bcp.14868. Epub 2021 May 5.

DOI:10.1111/bcp.14868
PMID:33871897
Abstract
摘要

相似文献

1
Pharmacovigilance-based drug repurposing: The search for inverse signals via OpenVigil identifies putative drugs against viral respiratory infections.基于药物警戒的药物重新利用：通过OpenVigil寻找反向信号以确定抗病毒性呼吸道感染的潜在药物。
Br J Clin Pharmacol. 2021 Nov;87(11):4421-4431. doi: 10.1111/bcp.14868. Epub 2021 May 5.
2
Repurposing of drugs against bacterial infections: A pharmacovigilance-based data mining approach.药物再利用防治细菌感染：基于药物警戒的数据分析方法。
Drug Dev Res. 2024 Jun;85(4):e22211. doi: 10.1002/ddr.22211.
3
Drug Repurposing: A Strategy for Discovering Inhibitors against Emerging Viral Infections.药物重定位：发现抗新兴病毒感染抑制剂的策略。
Curr Med Chem. 2021;28(15):2887-2942. doi: 10.2174/0929867327666200812215852.
4
Potential Repurposing of Drugs with Anti-SARS-CoV-2 Activity in Preclinical Trials: A Systematic Review.在临床前试验中具有抗 SARS-CoV-2 活性的药物的潜在再利用：系统评价。
Curr Med Chem. 2021;28(22):4577-4585. doi: 10.2174/0929867327666201005113204.
5
Disproportionality analysis in VigiBase as a drug repositioning method for the discovery of potentially useful drugs in Alzheimer's disease.利用 VigiBase 进行不均衡分析，作为一种药物重定位方法，以发现阿尔茨海默病中具有潜在用途的药物。
Br J Clin Pharmacol. 2021 Jul;87(7):2830-2837. doi: 10.1111/bcp.14690. Epub 2020 Dec 23.
6
Repurposed drugs for COVID-19: threshold and proof requirements for trials.用于治疗新冠肺炎的 repurposed 药物：试验的阈值和证据要求。
Clin Microbiol Infect. 2021 Dec;27(12):1716-1717. doi: 10.1016/j.cmi.2021.08.024. Epub 2021 Sep 8.
7
COVID-19: A Defining Moment for Clinical Pharmacology?新型冠状病毒肺炎：临床药理学的决定性时刻？
Clin Pharmacol Ther. 2020 Jul;108(1):11-15. doi: 10.1002/cpt.1876.
8
Repurposing host-based therapeutics to control coronavirus and influenza virus.基于宿主的治疗药物的再利用以控制冠状病毒和流感病毒。
Drug Discov Today. 2019 Mar;24(3):726-736. doi: 10.1016/j.drudis.2019.01.018. Epub 2019 Jan 31.
9
Identification of potential inhibitors of SARS-COV-2 endoribonuclease (EndoU) from FDA approved drugs: a drug repurposing approach to find therapeutics for COVID-19.从 FDA 批准的药物中鉴定 SARS-CoV-2 内切核糖核酸酶（EndoU）的潜在抑制剂：一种用于寻找 COVID-19 治疗方法的药物再利用方法。
J Biomol Struct Dyn. 2021 Aug;39(12):4201-4211. doi: 10.1080/07391102.2020.1775127. Epub 2020 Jun 9.
10
Repurposing old drugs as antiviral agents for coronaviruses.将老药重新用作冠状病毒的抗病毒药物。
Biomed J. 2020 Aug;43(4):368-374. doi: 10.1016/j.bj.2020.05.003. Epub 2020 May 23.

引用本文的文献

1
Spotlight commentary: Using real-world data for real-world evidence generation to advance drug repurposing.聚焦评论：利用真实世界数据生成真实世界证据以推进药物再利用
Br J Clin Pharmacol. 2025 Sep;91(9):2490-2493. doi: 10.1002/bcp.70181. Epub 2025 Jul 24.
2
Cardiovascular toxicities associated with vascular endothelial growth factor receptor tyrosine kinase inhibitors: a pharmacovigilance study based on FDA adverse event reporting system.血管内皮生长因子受体酪氨酸激酶抑制剂相关的心血管毒性：一项基于美国食品药品监督管理局不良事件报告系统的药物警戒研究
Int J Clin Pharm. 2025 Jul 2. doi: 10.1007/s11096-025-01962-8.
3
A disproportionality analysis of cardiac arrhythmia associated with bisphosphonates based on the FAERS database.
基于FAERS数据库的双膦酸盐类药物相关心律失常的不成比例性分析。
Sci Rep. 2025 Jul 1;15(1):20753. doi: 10.1038/s41598-025-00900-y.
4
An integrated approach based on FDA adverse event reporting system, network pharmacology, molecular docking, and molecular dynamics simulation analysis to study the cardiac adverse reactions and mechanism of action of osimertinib.基于美国食品药品监督管理局不良事件报告系统、网络药理学、分子对接和分子动力学模拟分析的综合方法，以研究奥希替尼的心脏不良反应及其作用机制。
Front Pharmacol. 2025 Jun 9;16:1619517. doi: 10.3389/fphar.2025.1619517. eCollection 2025.
5
Peripheral neuropathy associated with immunomodulatory drugs: a pharmacovigilance analysis based on the FDA adverse event reporting system database.免疫调节药物相关的周围神经病变：基于美国食品药品监督管理局不良事件报告系统数据库的药物警戒分析
Int J Clin Pharm. 2025 May 20. doi: 10.1007/s11096-025-01925-z.
6
Gastrointestinal adverse events associated with Lenvatinib versus Lenvatinib plus Pembrolizumab: A pharmacovigilance study in FDA adverse event reporting system.与乐伐替尼单药相比，乐伐替尼联合帕博利珠单抗治疗的胃肠道不良事件：一项基于美国食品药品监督管理局不良事件报告系统的药物警戒研究
Sci Rep. 2025 Apr 29;15(1):15047. doi: 10.1038/s41598-025-99773-4.
7
A real-world pharmacovigilance study of netarsudil based on the FDA adverse event reporting system (FAERS).一项基于美国食品药品监督管理局不良事件报告系统（FAERS）的奈他地尔真实世界药物警戒研究。
BMC Pharmacol Toxicol. 2025 Apr 21;26(1):88. doi: 10.1186/s40360-025-00927-x.
8
Comparison of serious adverse effects of methylphenidate, atomoxetine and amphetamine in the treatment of ADHD: an adverse event analysis based on the FAERS database.哌甲酯、托莫西汀和苯丙胺治疗注意缺陷多动障碍的严重不良反应比较：基于FAERS数据库的不良事件分析
BMC Pharmacol Toxicol. 2025 Feb 20;26(1):38. doi: 10.1186/s40360-025-00868-5.
9
A comprehensive, population level evaluation of previously reported drug triggers of pemphigus highlights immunomodulatory capacity as a common characteristic.一项针对先前报道的天疱疮药物触发因素的全面、基于人群水平的评估突出了免疫调节能力这一共同特征。
Front Immunol. 2025 Jan 21;15:1508129. doi: 10.3389/fimmu.2024.1508129. eCollection 2024.
10
Evaluation of link between COVID-19 adjacent spike in hydroxychloroquine use and increased reports of pemphigus: a disproportionality analysis of the FDA Adverse Event Reporting System.评估羟氯喹使用量的新冠相关激增与天疱疮报告增加之间的关联：对美国食品药品监督管理局不良事件报告系统的不成比例性分析
Front Immunol. 2024 Dec 20;15:1470660. doi: 10.3389/fimmu.2024.1470660. eCollection 2024.